Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The objective for this pilot study is to develop an optimized, clinically usable myocardial
PET-MR perfusion protocol and to determine which of all data potentially available should be
acquired for a clinical myocardial perfusion examination. Hypothesis: The hypothesis is that
high resolution, high sensitivity DCE MRI could replace the rest PET myocardial perfusion
imaging, significantly decreasing examination time and patient radiation dose while
maintaining the comprehensive reference-quality PET myocardial stress perfusion coverage.
The primary outcome will be comparison of diagnostic accuracy of each combination of imaging
to detect clinically significant coronary artery stenosis (≥70% diameter stenosis).